S. 2516 (112th): Food and Drug Administration Safety and Innovation Act

Introduced:

May 7, 2012
112th Congress, 2011–2013

Status:
Died in a previous Congress

This bill was introduced on May 7, 2012, in a previous session of Congress, but was not enacted.

Sponsor:

Thomas “Tom” Harkin
Senator from Iowa
Democrat

Text:

Read Text »
Last Updated: May 7, 2012
Length: 314 pages

See Instead:

S. 3187 (same title)
Enacted — Signed by the President — Jul 9, 2012

About the bill

Full Title

An original bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

Read CRS Summary >

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

S. 3187 (Related)
Food and Drug Administration Safety and Innovation Act

Enacted — Signed by the President
Jul 9, 2012

H.R. 5651 (Related)
Food and Drug Administration Reform Act of 2012

Passed House
Last Action: May 30, 2012

What is a bill?

The “S.” in “S. 2516” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

The bill’s title was written by its sponsor.

History

Introduced
May 7, 2012
Reported by Committee
May 7, 2012

Details

Cosponsors
none
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.

Votes

There have been no votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Citation

Click a format for a citation suggestion: